GeneProof CT/NG/MG Multiplex PCR Kit

GeneProof CT/NG/MG Multiplex PCR Kit

CE1023IVD

in develepment

PRODUCT DETAIL

The PCR kit is designed for Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium detection by the real-time Polymerase Chain Reaction (PCR) method.

The C. trachomatis detection consists in amplification of both the cryptic plasmid multi-copy sequence and the 16S rRNA gene specific for C. trachomatis and in measurement of fluorescence increase. The N. gonorrhoeae detection consists in amplification of multi-copy sequence of the gene encoding 16S rRNA and porA pseudogene and in measurement of fluorescence increase. The M. genitalium detection consists in amplification of a multicopy sequence of the gene encoding the 16S rRNA and in measurement of fluorescence increase. The C. trachomatis presence is indicated by the FAM fluorophore, N. gonorrhoeae by Cy5 fluorophore and M. genitalium by Texas Red fluorophore fluorescence growth.

An Internal Standard (IS) is either included in the reaction mix, controlling the possible inhibition of the PCR (ISIN version) or excluded, controlling also the DNA extraction process quality (ISEX version). IS positive amplification is detected in the HEX fluorophore fluorescence channel. The detection kit takes advantage of the "hot start" technology, minimizing non-specific reactions and assuring maximum sensitivity. Ready to Use MasterMix contains uracil-DNA glycosylase (UDG), eliminating possible contamination of the PCR by amplification products. The kit is designed for in vitro diagnostics and provides qualitative detection.

 

Technology real-time PCR
Type of analysis qualitative
Target Sequence the cryptic plasmid sequence and the 16S rRNA gene for Chlamydia trachomatis
the 16S rRNA gene and porA pseudogene for Neisseria gonorrhoeae
the 16S rRNA gene for Mycoplasma genitalium
Analytical Specificity Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium, 100 %
Analytical Sensitivity (LoD) reaches up to 0.177 cp/μl with the probability of 95 % (on Amplirun® Chlamydia trachomatis DNA control, Vircell)
reaches up to 0.22 cp/μl with the probability of 95 % (on Amplirun® Neisseria gonorrhoeae DNA control, Vircell)
reaches up to 1.129 cp/μl with the probability of 95 % (on Amplirun® Mycoplasma genitalium DNA control, Vircell)
Diagnostic Specificity 96.89 % (CI95%: 93.04% - 98.73%)
Diagnostic Sensitivity 97.67 % (CI95%: 86.20% - 99.88%)
Extraction/Inhibition Control PCR inhibition control (ISIN version)
PCR inhibition and DNA extraction efficiency control (ISEX version)
Validated Specimen swab, urine
Storage -20 ± 5 °C
Validated Extraction Methods croBEE NA16 Nucleic Acid Extraction System
GeneProof PathogenFree DNA Isolation Kit
Instruments croBEE Real-Time PCR System*
Applied Biosystems 7500 Real-Time PCR System
CFX96™/ Dx Real-Time PCR Detection System
Mic qPCR Cycler
QuantStudioTM 5 Real-Time PCR System
Rotor-Gene 3000 / Q
Required Detection Channels FAM, HEX, Cy5, Texas Red
External Quality Assessment regularly tested by QCMD and Instand e.V. External Quality Assessment Panels - results at www.geneproof.com
Regulatory Status CE1023IVD

* Validated instruments

ORDER INFORMATION

Product name Cat. No. Technology Package
GeneProof CT/NG/MG Multiplex PCR Kit CNMX/ISEX/025 real-time PCR 25 reactions
GeneProof CT/NG/MG Multiplex PCR Kit CNMX/ISEX/050 real-time PCR 50 reactions
GeneProof CT/NG/MG Multiplex PCR Kit CNMX/ISEX/100 real-time PCR 100 reactions

Comments are closed.